Treatment with glatiramer acetate reduces T1 and T2-weighted magnetic resonance imaging activity in patients with clinically isplated syndrome suggestive of multiple sclerosis.
- MA Rocca (Author)
- G Comi (Author)
- A Carra (Author)
- Franz Fazekas (Author)
- P Rieckmann (Author)
- O Bajenaru (Author)
- J Hillert (Author)
- I Elovaara (Author)
- C Young (Author)
- D Wynn (Author)
- J King (Author)
- C Lubetzki (Author)
- H Hartung (Author)
- KM Myhr (Author)
- C Espeyo (Author)
- S Komoly (Author)
- M Filippi (Author)
Activity: Talk, presentation or poster › Poster